CD274 and non-small cell lung carcinoma: Leica Biosystems has internally developed a PD-L1 CAL10 assay to examine its performance in NSCLC tissue, utilizing Leica Biosystems immunohistochemical staining tools and using TPS, a standardized scoring algorithm.